Munich has examined the impact of adding cognitive training to aerobic exercise in multi-episode schizophrenia patients. This combination led to increased verbal memory and improved global functioning. Increase in left temporal grey matter volume is a promising brain mechanism of action. Dr. Keith Nuechterlein from UCLA will present results from a recently completed RCT of first-episode schizophrenia patients in which aerobic exercise training was added to computerized cognitive training to determine the extent to which it could enhance the impact of cognitive training. He will show that this combination significantly enhances cognition and work/school functioning gains beyond the effect of cognitive training alone and leads to increases in prefrontal cortical thickness and functional connectivity. Furthermore, he will examine early BDNF increases in response to treatment as a predictor of later cognitive and functional improvements. Dr. Peter Falkai will lead the discussion of the promise of aerobic exercise as an intervention to improve physical health, cognition, and functional outcome in schizophrenia and consider the potential mechanisms of action.
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EFFECT OF INTERVAL

University Hospital of Montreal
Background: Among adults with psychotic disorders, negative symptoms as unhealthy lifestyle habits contribute to a high prevalence of metabolic syndrome and obesity. Lifestyle interventions, mainly physical activity (PA) has emerged as an essential component. Furthermore, interval training (IT) was found to be efficacious in other populations but poorly studied among people with psychosis. The objective was to determine the effects of a 6-month IT program on metabolic, anthropometric, and psychiatric/functional outcomes. Methods: Randomized controlled trial comparing the effects of a bi-weekly 30 minutes supervised IT program to a waiting list of overweight individuals with psychosis. Body composition and metabolic risk factors (blood pressure, insulin resistance, lipid profile) were measured at baseline and every 3 months. The groups were compared on an intent to treat basis with repeated-measures mixed linear models with the restricted maximum of likelihood method of estimation. Results: Sixty-seven individuals (28 control: waiting list; 39 IT intervention) with psychosis (60.6% men, mean age: 31.0 ± 7.2 years old; BMI: 32.0 ± 6.1 kg/m 2 , waist circumference: 107.7 ± 13.3 cm) were included in the study, and 67.2% completed the study. Attendance for the IT sessions was 61.8% and the dropout rate was 32%. IT was associated with significant improvements on waist circumference (-2.72 cm, SE = 1.34; p = 0.04), negative symptoms (-2.93, SE = 1.34; p = 0.03), social (SOFAS) (+5.23, SE = 2.39; p = 0.03) and global functioning (+7.34, SE = 2.05; p < 0.001). The effects of exercise in the first-episode psychosis (FEP) sub-group were similar to those of the entire cohort. Discussion: These promising results suggest that IT may be used as a treatment strategy for the management of metabolic complications and possibly improve social functioning in obese individuals with psychotic disorders. Further studies are needed to understand if IT could prevent weight gain and metabolic complications if used before these comorbidities emerge and to understand factors associated with the persistence of exercising. Background: Individuals with schizophrenia (SZ) display substantial cognitive deficits across multiple domains. These deficits have been identified as major determinants of poor functioning and disability, representing a serious public health concern and an important target for interventions. At present, available treatments offer only minimal to limited benefits to ameliorate these deficits. Thus, there remains an urgent need to identify novel treatments for cognitive deficits in people with SZ. Emerging evidence from studies of animals, clinical and non-clinical populations suggest that Aerobic Exercise (AE) is efficacious in improving cognition via up-regulation of Brain-Derived Neurotrophic Factor (BDNF). Yet, the impact of AE on cognition and daily-functioning, and the role of BDNF, have not been investigated in schizophrenia. Additionally, limited information is available on the putative link between inflammation markers to cognitive functioning. Methods: Employing a single-blind RCT design, 33 individuals with schizophrenia were randomized to receive "treatment as usual" (n=17; TAU) or attend a 12-week, 3 times-per-week, 60-minutes AE program (n=16) utilizing active-play video-games (Xbox-360 Kinect) and traditional AE equipment. Results: At baseline, cognitive functioning was associated with serum BDNF (r=.51, p=.01), along with TNF-alpha (r=-.38, p=.03), p=.06) . Twenty-six participants completed the study (79%). Following the intervention, the AE participants improved their cognitive functioning (MCCB) by 15.1% (vs. -2.0% in the TAU group; p=.03). Hierarchical multiple-regression analyses indicated changes in AF and serum BDNF predicted 25.4% and 14.6% of the cognitive improvement, respectively. Additionally, changes in aerobic fitness (VO2peak ml/kg/min) correlated with informant-reported improvements in work-related daily-functioning skills (SLOF; r=.51, p=.01). Fidelity with target training intensity, was correlated with cognitive improvement (r=.70, p=.02). Discussion: The results indicate AE is effective in enhancing cognitive and daily functioning skills in people with schizophrenia and provide support for the impact of AE-related BDNF up-regulation on cognition. Additional studies are needed to establish the link between inflammation markers and cognitive functioning and the potential impact of AE on this putative pathway. Overall, low aerobic fitness represents a modifiable risk-factor for cognitive dysfunction in schizophrenia for which AE training offer a relatively safe, non-stigmatizing, and side-effect-free intervention. 
THE IMPACT OF AEROBIC EXERCISE ON COGNITIVE FUNCTIONING AND BIOMARKERS OF COGNITIVE CHANGE IN INDIVIDUALS
CLINICAL AND NEUROBIOLOGICAL EFFECTS OF A CONTINUOUS AEROBIC
